Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

Are we ready to endorse new multiple cancer early-detection tests?

Breadcrumb

  • Home
  • Are we ready to endorse new multiple cancer early-detection tests?

Felix Wu Shun WONG 1, * and Bee Luan KHOO 2

1 Women and Babies Clinic, Central Building, Hong Kong, SAR, China.
2 Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, SAR, China.
 
Short Communication
World Journal of Advanced Research and Reviews, 2023, 17(02), 800-802
Article DOI: 10.30574/wjarr.2023.17.2.0325
DOI url: https://doi.org/10.30574/wjarr.2023.17.2.0325
 
Received on 13 January 2023; revised on 16 February 2023; accepted on 24 February 2023
 
Cancer detection tests open a new era of developing cancer markers, allowing early detection and improving cancer treatments. Existing cancer detection technologies, for example, CA125, CA 19.9, CT, MRI, and others, are either not highly sensitive or specific enough for early detection. Recent technological development of “liquid biopsy” research led to more sensitive biomarkers. Newly developed multiple-cancer early-detection tests can screen up to multiple cancers in asymptomatic individuals with one blood draw. These tests, however, might pose significant challenges in our clinical practice. This paper highlights the issues we face and how to solve their problems.
 
Cancer detection test; Biomarkers; MCED tests; NHS-Galleri trial
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2023-0325.pdf

Preview Article PDF

Felix Wu Shun WONG and Bee Luan KHOO. Are we ready to endorse new multiple cancer early-detection tests?. World Journal of Advanced Research and Reviews, 2023, 17(2), 800-802. Article DOI: https://doi.org/10.30574/wjarr.2023.17.2.0325

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution